Medicare Enrolled
Dr. Kolo Ediale, M.D.
Endocrinology · Monticello, NY
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ediale from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ediale?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ediale
Dr. Kolo Ediale is an endocrinology specialist in Monticello, NY, with 21 years of NPI registration. Based on federal Medicare data, Dr. Ediale performed 7,916 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Ediale received a total of $27,143 from 43 pharmaceutical and/or device companies across 1196 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ediale is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 9% volume in NY
$27,143 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗7,916
Medicare services
Top 9% in NY for endocrinology
Not available
Unique patients (not deduplicated)
$26
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 5,220 | $18 | $24 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
759 | $102 | $141 |
| Blood glucose test using hand-held instrument A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels. |
548 | $3 | $3 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
390 | $9 | $10 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
159 | $12 | $15 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
113 | $7 | $7 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
88 | $10 | $11 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
81 | $8 | $8 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
80 | $16 | $17 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
69 | $7 | $7 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
69 | $6 | $7 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $139 | $187 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
52 | $13 | $14 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
48 | $29 | $30 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
43 | $32 | $42 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
35 | $15 | $15 |
| Smoking cessation counseling, 4-10 minutes A brief counseling session focused on helping patients quit smoking and tobacco use. The provider spends 4 to 10 minutes discussing strategies and support for cessation. |
33 | $16 | $16 |
| Ultrasound of head and neck soft tissue This procedure uses sound waves to create images of the soft tissues in the head and neck area. It allows for the visualization of structures beneath the skin without using radiation. |
31 | $71 | $102 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
27 | $72 | $98 |
| Microsomal antibody test A blood test that measures the level of microsomal antibodies, which are autoantibodies produced by the immune system. |
11 | $14 | $15 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$27,143
Total received (2018-2024)
Avg $3,878/year across 7 years
Top 14% in NY for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
1,196
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$697
2023
$2,590
2022
$3,501
2021
$3,459
2020
$2,894
2019
$6,908
2018
$7,096
Payments by company (2024)
Lilly USA, LLC
$157
Novo Nordisk Inc
$132
CSL Behring
$64
Amgen Inc.
$63
Antares Pharma, Inc.
$50
Abbott Laboratories
$47
Corcept Therapeutics
$46
RECORDATI_RARE_DISEASES_INC.
$42
SANOFI-AVENTIS U.S. LLC
$29
Radius Health, Inc.
$26
ABBVIE INC.
$24
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Top 3 companies account for 50.5% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$4,236
SANOFI-AVENTIS U.S. LLC
$2,927
Lilly USA, LLC
$2,865
Amgen Inc.
$2,203
Corcept Therapeutics
$1,582
AstraZeneca Pharmaceuticals LP
$1,371
Janssen Pharmaceuticals, Inc
$1,330
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,254
Antares Pharma, Inc.
$1,057
Abbott Laboratories
$927
Novartis Pharmaceuticals Corporation
$901
Radius Health, Inc.
$871
Merck Sharp & Dohme Corporation
$777
Amarin Pharma Inc.
$681
Medtronic MiniMed, Inc.
$617
AbbVie, Inc.
$436
Bayer HealthCare Pharmaceuticals Inc.
$397
AbbVie Inc.
$342
Xeris Pharmaceuticals, Inc.
$225
Insulet Corporation
$215
Mannkind Corporation
$200
Lundbeck LLC
$176
RECORDATI_RARE_DISEASES_INC.
$155
ABBVIE INC.
$150
IBSA Pharma Inc.
$143
Bayer Healthcare Pharmaceuticals Inc.
$143
Medtronic, Inc.
$125
Amneal Pharmaceuticals LLC
$115
Supernus Pharmaceuticals, Inc.
$94
Dexcom, Inc.
$94
Clarus Therapeutics Inc.
$91
MannKind Corporation
$74
CSL Behring
$64
Shire North American Group Inc
$56
Alexion Pharmaceuticals, Inc.
$52
Tandem Diabetes Care, Inc.
$47
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$36
Ultragenyx Pharmaceutical Inc.
$27
DEXCOM, INC.
$22
Acella Pharmaceuticals, LLC
$21
Esperion Therapeutics, Inc.
$19
Merck Sharp & Dohme LLC
$15
Janssen Biotech, Inc.
$11
Top 3 companies account for 36.9% of all-time payments
Associated products mentioned in payments ›
AFREZZA · APRISO · Androgel · BAQSIMI · BASAGLAR · BYDUREON · CRYSVITA · CYCLOSET · Corlanor · Creon · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · FARXIGA · FORTEO · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GUARDIAN CONNECT · GVOKE PFS · Guardian Connect · HUMULIN · HUMULIN R 500 · Hizentra · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LANTUS · LINZESS · LOKELMA · LYUMJEV · MOUNJARO · Minimed 630G · Minimed 670G System · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NOCDURNA · NORTHERA · NP Thyroid 60 · OTREXUP · Omnipod · Otrexup · Ozempic · Prolia · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SIMPONI · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYNTHROID · Saxenda · Strensiq · Synthroid · TLANDO · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Tirosint · Tresiba · Tymlos · UNITHROID · Vascepa · Victoza · Wegovy · XARELTO · XYOSTED · t-slim insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Endocrinologists in nearby ZIP areas
9
County median income
$69,826
Nearest hospital to ZIP centroid (approximate)
GARNET HEALTH MEDICAL CENTER CATSKILLS
5.1 mi
5.1 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ediale is a mixed practice specialist, with above-average Medicare volume (top 9% in NY), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ediale experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Ediale performed 5,220 denosumab injection (prolia/xgeva) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Ediale receive payments from pharmaceutical companies?
Yes. Dr. Ediale received a total of $27,143 from 43 companies across 1,196 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ediale's costs compare to other endocrinologists in Monticello?
Dr. Ediale's average Medicare payment per service is $26. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ediale) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologists in Monticello
Browse endocrinologists in Monticello ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologists in NY
Endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologists in NY
Which NY endocrinologists receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
SANOFI-AVENTIS U.S. LLC Payments to Doctors
See all physicians who received payments from SANOFI-AVENTIS U.S. LLC.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology